Related Articles
Potential suppressive effects of gentian violet on human breast cancer MDA-MB-231 cells in vitro: Comparison with gemcitabine
Zn(II)-curc targets p53 in thyroid cancer cells
Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells
BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells
PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein